Davis Krista 4

What Happened

• Krista Davis, SVP & Chief HR Officer of Ani Pharmaceuticals (ANIP), was granted 10,810 restricted shares on 2026-02-26 valued at $77.15 each (total value ~$833,992). Two days later (2026-02-28) 1,555 shares were withheld/disposed to cover tax liabilities at $73.90 per share (proceeds/value ~$114,915).
• The 10,810-share grant is a restricted stock award (an award/grant, code A), not an open-market purchase or sale; such awards are routine compensation rather than a direct bullish purchase signal.

Key Details

• Grant date and value: 2026-02-26 — 10,810 restricted shares @ $77.15 = $833,992 (code A).
• Tax withholding: 2026-02-28 — 1,555 shares withheld/disposed @ $73.90 = $114,915 (code F).
• Vesting: The new 10,810-share award vests in four equal annual installments on each anniversary of 2/26/2026 (footnote F1).
• The 1,555-share withholding relates to tax payment; filing notes 1,555 shares withheld in connection with vesting activity and references a prior vesting of 3,040 shares (footnote F2).
• Shares owned after the transactions are not specified in the Form 4.
• Filing: Form 4 was filed 2026-03-02 (timely relative to the reported transaction dates).

Context

• Restricted stock awards are common executive compensation and vest over time; they do not represent an immediate open-market purchase.
• The F code transaction is a tax-withholding disposition (shares withheld to satisfy tax liability), which is administrative and not generally interpreted as a market sentiment signal.